- Home
- PCRX vs VVR Comparison
PCRX vs VVR Comparison
Compare PCRX & VVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- VVR
- Stock Information
- Founded
- PCRX 2006
- VVR 1998
- Country
- PCRX United States
- VVR United States
- Employees
- PCRX N/A
- VVR N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- VVR Trusts Except Educational Religious and Charitable
- Sector
- PCRX Health Care
- VVR Finance
- Exchange
- PCRX Nasdaq
- VVR Nasdaq
- Market Cap
- PCRX 604.7M
- VVR 588.8M
- IPO Year
- PCRX 2011
- VVR N/A
- Fundamental
- Price
- PCRX $22.84
- VVR $4.01
- Analyst Decision
- PCRX Buy
- VVR
- Analyst Count
- PCRX 10
- VVR 0
- Target Price
- PCRX $27.60
- VVR N/A
- AVG Volume (30 Days)
- PCRX 787.3K
- VVR 692.2K
- Earning Date
- PCRX 02-27-2025
- VVR 01-01-0001
- Dividend Yield
- PCRX N/A
- VVR 11.38%
- EPS Growth
- PCRX N/A
- VVR N/A
- EPS
- PCRX N/A
- VVR N/A
- Revenue
- PCRX $694,957,000.00
- VVR N/A
- Revenue This Year
- PCRX $4.83
- VVR N/A
- Revenue Next Year
- PCRX $2.16
- VVR N/A
- P/E Ratio
- PCRX N/A
- VVR N/A
- Revenue Growth
- PCRX 4.40
- VVR N/A
- 52 Week Low
- PCRX $11.16
- VVR $3.55
- 52 Week High
- PCRX $34.01
- VVR $4.38
- Technical
- Relative Strength Index (RSI)
- PCRX 72.97
- VVR 53.49
- Support Level
- PCRX $18.18
- VVR $3.93
- Resistance Level
- PCRX $22.36
- VVR $4.11
- Average True Range (ATR)
- PCRX 1.17
- VVR 0.06
- MACD
- PCRX 0.33
- VVR 0.01
- Stochastic Oscillator
- PCRX 99.15
- VVR 50.00
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About VVR Invesco Senior Income Trust (DE)
Invesco Senior Income Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide a high level of current income, consistent with the preservation of capital. The company invests in a portfolio of interests in floating or variable senior loans to corporations, partnerships, and other entities which operate in a variety of industries and geographic regions.